SCLDSCCL
BMY icon

Split Creek LLC DBA Split Creek Capital LLC’s Bristol-Myers Squibb BMY Stock Holding History

Split Creek LLC DBA Split Creek Capital LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Sell
5,223
-13
-0.2% -$746 0.28% 102
2026
Q1 		$318K Buy
5,236
+1,462
+39% +$85.2K 0.33% 88
2025
Q4 		$204K Buy
+3,774
New +$182K 0.22% 123

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Split Creek LLC DBA Split Creek Capital LLC's BMY Position: Q2 2026 in Review

Split Creek LLC DBA Split Creek Capital LLC reduced its Bristol-Myers Squibb (BMY) stake by 0.25% in Q2 2026, selling an estimated $746 and leaving 5,223 shares worth $301K. The position accounts for 0.28% of the portfolio, ranked #102.

Split Creek LLC DBA Split Creek Capital LLC first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $318K in Q1 2026. 2,536 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Split Creek LLC DBA Split Creek Capital LLC held 5,223 shares of Bristol-Myers Squibb worth $301K as of Q2 2026.
  • Split Creek LLC DBA Split Creek Capital LLC sold 13 Bristol-Myers Squibb shares in Q2 2026, an estimated $746.
  • Bristol-Myers Squibb made up 0.28% of Split Creek LLC DBA Split Creek Capital LLC's portfolio in Q2 2026, its #102 holding.
  • Split Creek LLC DBA Split Creek Capital LLC first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Split Creek LLC DBA Split Creek Capital LLC's Bristol-Myers Squibb position peaked at $318K in Q1 2026.
  • 2,536 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Split Creek LLC DBA Split Creek Capital LLC's 13F filing for Q2 2026, filed 23 Oct 2026.